lecture 4: principles of enzyme catalysis reading: berg, tymoczko & stryer: chapter 8
DESCRIPTION
LECTURE 4: Principles of Enzyme Catalysis Reading: Berg, Tymoczko & Stryer: Chapter 8. An ENZYME is a biomolecular catalyst that accelerates the rate of a specific reaction Enzymes DO NOT make a chemical reaction more energetically favorable; - PowerPoint PPT PresentationTRANSCRIPT
LECTURE 4: Principles of Enzyme CatalysisReading: Berg, Tymoczko & Stryer: Chapter 8
An ENZYMEENZYME is a biomolecular catalyst that accelerates the rate of a specific reaction
Enzymes DO NOT make a chemical reaction more energetically favorable;They only ACCELERATE the rate of the reaction towards its energetic equilibrium
Enzymes work by stabilizing chemical transition states, the high-energy intermediatesthat normally act as a barrier to spontaneous reaction
Most enzymes are FOLDED PROTEINS: proteins have the ability to fold into scaffoldswith binding surfaces for substrates that position the substrates for chemical reaction
A few enzymes are RNA molecules! RNAs also have ability to adopt tertiary structures.Some RNAs (called RIBOZYMES) act as enzymes catalyzing their own site-specific cleavage
or that of other RNA molecules
As catalysts, enzymes are NOT CONSUMED during reactions.
S + E -----> ES -------> P + E
In some cases, enyzmes are chemically modified during catalysis, but return to theiroriginal form after reaction cycle to allow further catalysis of substrate
S + E -----> E*S -------> P + E
Proteases Are Examples of Enzymes That Catalyze An Energetically Favored Process
Fig 8.0new (peptide hydryolys)
Peptide hydrolysis is an energetically favorable process, but normally occurs very slowly.PROTEASES are enzymes that catalyze peptide hydrolysis.Some proteases are rather NONSELECTIVE (e.g., papain)
Other proteases are VERY SELECTIVE (e.g., trypsin, thrombin, fibrin)
Fig 8.1new
Some Enzymes Employ Cofactors
Some enzymes use cofactors as part of the active site in enzymatic catalysis
APOENZYME + COFACTOR --------> HOLOENZYME
Many cofactors cannot be synthesized by humans, and must be obtainedthrough diet as vitamins and minerals
Tab8.2new
Free Energy of Biochemical Reactions
For reaction A + B C + D
G is the differential in free energy between the products vs. reactants
If G < 0, reaction is energetically favorable I.e., reactants will convert to products as system moves to equilibrium
If G = 0, reaction is already at equilibrium I.e., there will be no NET conversion of reactants to products
If G > 0, reaction is disfavored I.e., products will convert to reactants as system moves to equilibrium; the reverse reaction is favored
Free energy G is usually expressed in units kcal/mol or kcal x mol-1
Standard Free Energy is Related to Equilibrium Constant
For reaction A + B C + D
G = G o + RT ln[C] [D]
[A] [B]
G is free energy change when reactant and product concentrations are [A],[B],[C],[D]
Go is free energy change when reactant and product concentrations are each 1M
WHAT DOES THIS MEAN?
Go is measure of whether reactants or products are favored if all components are at same concentration
The actual concentration of reactants and products impacts on G;
even if Go is unfavorable, high ratio of reactants to products can give favorable G
Go can be related to the equilibrium constant, Keq, of the reaction
Keq =[C]eq[D]eq
[A]eq[B]eq
Since G o = - RT lnKeq = - 2.3RT log10Keq
G o = - RT lnKeq = - 2.3RT log10Keq
Tab8.3new
Enzymes Accelerate Rate Constant Without Altering Equilibrium Constant
S PWithout enzyme
With enzyme S P
Keq = kf / kr
Keq = kf / kr
=
Fig8.2new
Enzymes Stabilize Reaction Transition State(s)
Fig8.3new
Properties of Enzyme Active Sites
Active site consists of atoms on residue side chains that are brought together by the fold
Most of the enzyme structure is a scaffold to precisely position active site residues
Active site uses range of noncovalent bonding mechanisms to bind substrate
By binding multiple substrates in a favorable interspatial relationship and/or
by altering charge distribution (resonance) within substrates, Gtransition ismuch smaller than would be spontaneously
Fig8.7new Fig8.8new
The Michaelis-Menton Model of Enzyme Function
E + S ES E + Pk2
k-1
k1
k-2
At time=0, if [P]=0, then E + S ES E + Pk-1
k1
Vo = kcat [ES] [ES] determined by [E], [S], and rate constants
THESE EQUATIONS CAN BE SOLVED TO EXPRESS THE REACTION RATE AS A FUNCTION
OF THE SUBSTRATE CONCENTRATION [S] AND TWO INHERENT PROPERTIESOF THE ENZYME: KM AND kcat
Vo = VMAX
[S]
[S] + KM
Michaelis-Menton Equation
k2 kcat=
kcat
where
VMAX = kcat [E]
KM = k-1 /k1 = [E][S]/[ES]and
The Michaelis-Menton Equation: Meaning Behind The Terms
Fig8.12new
Vo = VMAX
[S]
[S] + KM
No matter how large the substrate concentration,
reaction rate can never exceed VMAX
VMAX reflects the TURNOVER RATE of substrate
molecules through the enzyme (kcat)
and the enzyme concentration
KM is the substrate concentration at which
reaction rate is HALF MAXIMAL
KM reflects the BINDING AFFINITY of the enzyme
for the substrate;
The higher the affinity, the smaller is Km
By performing experiments to calculate Voat different substrate concentrations,
properties VMAX and Km can be calculated
If the enzyme concentration is known, VMAX can
be used to calculate kcat
Lineweaver-Burk Plot Facilitates Calculation of KM and VMAX
Vo = VMAX
[S]
[S] + KM
By inverting equation, get:
Vo
1 1
VMAX
= + KM
VMAX( )1
[S]
Fig8.13new
Tab8.5new
Many Enzymatic Reactions Proceed Through Fixed Sequential Steps
PyrLac.p223new
TransAm.p224new
Reaction Intermediate May Utilize Covalently Modified Enzyme or Cofactor
Enzyme Inhibition
Many small molecules can bind to enzymes and inhibit them.
Inhibitors can be described as REVERSIBLE or IRREVERSIBLE.
Inhibitors may be naturally occuring within the homologous organism orin a heterologous organism
Other inhibitors are synthetic and have been developed as pharmaceuticalsfor research and clinical applications
COMPETITIVE INHIBITORS act by occupying the enzyme active sitein place of the substrate
NONCOMPETITIVE INHIBITORS bind away from the active site, but their bindingexerts allosteric effects that prevents bound substrate conversion to product
Fig8.15AnewFig8.15Bnew Fig8.15Dnew
Kinetics of Competitive Inhibition
Fig8.17new
Vo = VMAX
[S]
[S] + KM ( Ki
[ I ]1 + )
Ki reflects the AFFINITY OF INHIBITOR
for the enzyme
Inhibitor in effect raises the apparent KM term
The potency of inhibitor determined by Ki
Therefore, the amount of substrateneeded for half-maximum rate
is increased
THERE IS NO EFFECT ON VMAX
I.e., a competitive inhibitor can beovercome by sufficiently high
substrate concentration
Kinetics of Noncompetitive Inhibition
Fig8.19new
( Ki
[ I ]1 + )
Vo =[S]
[S] + KM
VMAX xAs before,
Ki reflects the AFFINITY OF INHIBITOR
for the enzyme
Inhibitor reduces VMAX of the enzyme
The potency of inhibitor determined by Ki
The inhibitor does not affect KM , i.e.,
the binding of substrate to enzyme